MSBase: an international, online registry and platform for collaborative outcomes research in multiple sclerosis. - Wikidata - awgldk - TriplyDB

MSBase: an international, online registry and platform for collaborative outcomes research in multiple sclerosis.

MSBase: an international, online registry and platform for collaborative outcomes research in multiple sclerosis.

http://www.wikidata.org/entity/Q36722176

about

Multiple sclerosis: clinical profiling and data collection as prerequisite for personalized medicine approach Country, sex, EDSS change and therapy choice independently predict treatment discontinuation in multiple sclerosis and clinically isolated syndrome The Australian Multiple Sclerosis (MS) immunotherapy study: a prospective, multicentre study of drug utilisation using the MSBase platform The Swiss Multiple Sclerosis Cohort-Study (SMSC): A Prospective Swiss Wide Investigation of Key Phases in Disease Evolution and New Treatment Options A comparative study on iMed(©) and European database for multiple sclerosis to propose a common language of multiple sclerosis data elements.A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data.Rationale, design, and methods of a non-interventional study to establish safety, effectiveness, quality of life, cognition, health-related and work capacity data on Alemtuzumab in multiple sclerosis patients in Germany (TREAT-MS).Data quality evaluation for observational multiple sclerosis registries.Neuroinflammation - using big data to inform clinical practice.Multiple sclerosis in Latin America: A different disease course severity? A collaborative study from the MSBase Registry Geographical variations in sex ratio trends over time in multiple sclerosis.Persistence on therapy and propensity matched outcome comparison of two subcutaneous interferon beta 1a dosages for multiple sclerosis Comparative efficacy of switching to natalizumab in active multiple sclerosis.Predictors of disability worsening in clinically isolated syndrome.Male Sex Is Independently Associated with Faster Disability Accumulation in Relapse-Onset MS but Not in Primary Progressive MS Designing an Electronic Patient Management System for Multiple Sclerosis: Building a Next Generation Multiple Sclerosis Documentation System.Comparative efficacy of first-line natalizumab vs IFN-β or glatiramer acetate in relapsing MS.Fingolimod after natalizumab and the risk of short-term relapse.Defining secondary progressive multiple sclerosis.Long-term disability trajectories in primary progressive MS patients: A latent class growth analysis.Treatment decisions in multiple sclerosis - insights from real-world observational studies.Discontinuing disease-modifying therapy in MS after a prolonged relapse-free period: a propensity score-matched study.Predictors of long-term disability accrual in relapse-onset multiple sclerosis.Response to interferon-beta treatment in multiple sclerosis patients: a genome-wide association study.Cladribine versus fingolimod, natalizumab and interferon β for multiple sclerosis.The effect of oral immunomodulatory therapy on treatment uptake and persistence in multiple sclerosis.Contribution of different relapse phenotypes to disability in multiple sclerosis.BREMSO: a simple score to predict early the natural course of multiple sclerosis.Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing-remitting multiple sclerosis.The importance of collecting structured clinical information on multiple sclerosis.Earlier disability of the patients followed in Multiple Sclerosis centers compared to outpatients.Predictors and dynamics of postpartum relapses in women with multiple sclerosis.SUMMIT (Serially Unified Multicenter Multiple Sclerosis Investigation): creating a repository of deeply phenotyped contemporary multiple sclerosis cohorts.Fair data for next-generation management of multiple sclerosis.Biogen's portfolio and research efforts in multiple sclerosis: an interview with Dr Ralph Kern.Towards personalized therapy for multiple sclerosis: prediction of individual treatment response.Deep brain stimulation for severe treatment-resistant obsessive-compulsive disorder: An open-label case series.Feeling severely affected by multiple sclerosis: what does this mean?Cortical dysfunction underlies disability in multiple sclerosis.Sex as a determinant of relapse incidence and progressive course of multiple sclerosis.

P2860

Q28080043-C3E95493-F29F-4781-B290-3AAD360B52D8 Q28480907-F4B7BF11-BBD7-4FC5-BA72-EC2C39F149EE Q28488248-09CB7495-D5C4-4A5C-B98F-B70989125581 Q28601505-4FB1D786-D247-4B10-A47B-C8603D0A0799 Q30881892-8BD8CF2B-86E4-402B-933E-96AA3E940E40 Q31034192-1E0D7E1E-6418-4569-B013-1642D82B3C7F Q31115496-6CA4BC5A-A5A7-491B-B79D-F7079F752328 Q31119031-322ED3E3-1A46-4DD5-954D-5469B30967A5 Q31142833-E501D4F7-92C2-4A5E-8E14-6C57AB3B691C Q33613668-EAE76CF1-A5B8-42DE-8E76-958D5BBA5321 Q34469310-7EAAA70B-BEF4-45D5-B6BC-DECD4DA42795 Q34737478-B815D71E-DB7C-446F-9BB2-F8DF0C3E659C Q35469575-52C338FF-93CB-4505-9330-4BFF916C9A00 Q35619185-BE290CB8-AF8D-4631-8CD8-A2B6FA2BC657 Q35653675-AE925672-5C3E-473A-A186-9C034F3361AD Q36492533-6618F8CB-6695-454F-A34A-745D7F7C88D1 Q36789883-02C91B8A-2C7B-4FD1-9750-5367EF0BD1C5 Q37725909-D2E8D551-077B-4F42-9C47-BCE3C69F406F Q38843046-F92F7180-42EA-4AC6-9283-E85309F378BA Q38850911-DDECDF7A-A1C6-4765-83AD-781ECD74896F Q39022643-20529111-7BFC-4291-AE32-57CFD113FEF6 Q39685700-DE871B19-45F4-40C2-A08B-75A939A7DD9B Q39795220-280F8B4B-52C9-4D5E-B2C7-BD18B6371FCE Q39900185-790E8762-DC2C-47AB-AA75-E07886D3F8B2 Q40073097-55CC2119-3D92-45EB-BD46-865BEC9DF2A8 Q40710140-D95B903D-473F-43B9-AC11-95B515D3E20B Q40724148-716B0617-5DAD-41FB-B849-0477B1079BBC Q41161179-CDCB8C12-DC1E-43A4-81DC-F1C92E302079 Q41721827-A89FCE09-0B6E-468D-841E-88F0E338CFF5 Q42747344-5FC31846-5E6D-48DF-AA61-20D15057B424 Q45823287-48AD410E-CE2D-469F-BA33-EB587CFCE942 Q45832934-E403D11D-5C46-4489-9334-8A5D502CDF9F Q46861116-697AF982-D16F-4949-BC9B-CE980C4AA7AE Q47288129-C773F303-A305-4EA7-BBEA-C3A8A257BE76 Q47589453-4C17D5D3-A60E-4012-8560-7EC64FF4BAEE Q47639943-C7E6E569-CAB1-4EEB-9094-1A3B5FA075BC Q47671470-2621594F-35D9-47C8-BFEE-F4E0F4488ECC Q48557268-ACE9E143-CD88-4D2F-A4A7-3A0CECE6D0AF Q48866769-9D32BB8B-8A66-4DF4-8551-10AD8A4913F4 Q48922719-7C26C18D-6090-4200-8CDA-69C8B2010361

P2860

MSBase: an international, online registry and platform for collaborative outcomes research in multiple sclerosis.

http://www.wikidata.org/entity/Q36722176

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

MSBase: an international, onli ...... esearch in multiple sclerosis.

@ast

MSBase: an international, onli ...... esearch in multiple sclerosis.

@en

type

label

MSBase: an international, onli ...... esearch in multiple sclerosis.

@ast

MSBase: an international, onli ...... esearch in multiple sclerosis.

@en

prefLabel

MSBase: an international, onli ...... esearch in multiple sclerosis.

@ast

MSBase: an international, onli ...... esearch in multiple sclerosis.

@en

P1433

Q36722176-79ABD069-612C-468B-9AF4-B2C986A10584

P1476

Q36722176-414AB6C2-480E-413E-A235-586CA56053DD

P2093

Q36722176-2CADF758-DD10-4676-8CD7-BF29894DB7B8

Q36722176-3A065F81-D797-4C39-B0F9-65B0B16DC5C0

Q36722176-3CE90D88-9302-4F57-A8ED-E3B34AF29DBA

Q36722176-565890A0-E13D-4768-908D-D40EF1D5509C

Q36722176-60EA3C4A-B203-4C38-804A-25D2E8ACC619

Q36722176-6D7912EA-D3A7-4F4A-B9A6-F410320BCFC3

Q36722176-73E4D1CA-32B6-4D27-B043-AE51D6251725

Q36722176-A99BFA99-4D83-42D8-B188-F60797F66FC6

Q36722176-AE6A6675-FBB8-4D4F-8787-69A3E05385CD

Q36722176-B5DD5DD2-5FDF-43D7-967C-066662BA6D33

P2860

Q36722176-091F27E2-80D3-4D0B-9C59-799D1FCFF822

Q36722176-46790D48-5251-4CCF-AB22-2A9FFB42D3AE

Q36722176-587C5923-FE55-4CF3-BFF6-22C9BBC88398

Q36722176-82757381-3FB2-42A2-A9A7-FEE4F7613D82

Q36722176-C484E902-4F01-46AB-A422-DA85A5060CE6

Q36722176-DCC43BFB-CF52-499D-B09A-5AF0A1B63A06

Q36722176-E790C50F-671C-4407-9810-B6EEF7470E5E

Q36722176-EDB443FC-6078-4222-A792-C3E2EE8E8EC3

Q36722176-F2D81986-A64A-4D02-B979-6F7E306EBD03

P304

Q36722176-0F904FA7-17CC-42DF-A122-E4C2C3F2E183

P31

Q36722176-E268D23F-F705-4A21-8B96-0EAF103A7D87

P356

Q36722176-773BE7F8-7C8D-414A-8C5E-97DB499F4A6B

P433

Q36722176-A234A59F-0F24-4195-813B-602AA39EECC9

P478

Q36722176-C29D863E-027B-447E-A7ED-31ED9FE37319

P50

Q36722176-F545C118-A253-4E14-922E-7B53F38BCDB5

P577

Q36722176-A7CC46E5-1D38-4092-96B0-A80EF41AFA6A

P5875

Q36722176-FBBA4721-A70B-4FF4-856D-02E071C4C962

P698

Q36722176-0AB7B500-1F34-4D95-A263-BD4D87682EE3

P921

Q36722176-4C54B4DC-DE1B-4131-BD4E-B04CEE2136C3

Q36722176-902E26A7-9E5A-42FF-96F5-D1BBB1E65BE9

P356

1352458506070775

P1433

Multiple Sclerosis Journal

P1476

MSBase: an international, onli ...... esearch in multiple sclerosis.

@en

P2093

D Jolley

http://www.w3.org/2001/XMLSchema#string

D Pöhlau

http://www.w3.org/2001/XMLSchema#string

E Cristiano

http://www.w3.org/2001/XMLSchema#string

F Grand'Maison

http://www.w3.org/2001/XMLSchema#string

F Verheul

http://www.w3.org/2001/XMLSchema#string

G Izquierdo

http://www.w3.org/2001/XMLSchema#string

J Chapman

http://www.w3.org/2001/XMLSchema#string

J P Malkowski

http://www.w3.org/2001/XMLSchema#string

L Kappos

http://www.w3.org/2001/XMLSchema#string

M Hoffmann

http://www.w3.org/2001/XMLSchema#string

P2860

The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability

A comparison of observational studies and randomized, controlled trials.

Randomized controlled trials to assess therapies for multiple sclerosis.

Current status of computerization of multiple sclerosis clinical data for research in Europe and North America: the EDMUS/MS-COSTAR connection. European Database for Multiple Sclerosis. Multiple Sclerosis-Computed Stored Ambulatory Record.

The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis.

The natural history of multiple sclerosis: a geographically based study. 6. Applications to planning and interpretation of clinical therapeutic trials in primary progressive multiple sclerosis.

Multiple sclerosis in Oslo, Norway: prevalence on 1 January 1995 and incidence over a 25-year period.

Risk of cancer from azathioprine therapy in multiple sclerosis: a case-control study.

Cognitive impairment: a key feature of congestive heart failure in the elderly.

P304

769-774

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1352458506070775

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

Helmut Butzkueven

P577

2006-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6541333

http://www.w3.org/2001/XMLSchema#string

P698

17263005

http://www.w3.org/2001/XMLSchema#string

P921

multiple sclerosis